CBIIF News and Press, Skylight Health Group From 03/30/20

TORONTO, March 30, 2020 (GLOBE NEWSWIRE) -- CB2 Insights (CSE:CBII; OTCQB: CBIIF) (“CB2” or the “Company”), a leading data-driven company focused on bringing real-world evidence driven from the point-of-care to the medical cannabis community, has launched the med...

TORONTO, Jan. 29, 2020 (GLOBE NEWSWIRE) -- CB2 Insights (CSE:CBII; OTCQB: CBIIF) (“CB2” or the “Company”), a leading data-driven company focused on bringing real-world evidence driven from the point-of-care to the medical cannabis community, is pleased to announc...

TORONTO, Jan. 27, 2020 (GLOBE NEWSWIRE) -- CB2 Insights (CSE:CBII; OTCQB: CBIIF) (“CB2” or the “Company”), a leading data-driven company focused on bringing real-world evidence driven from the point-of-care to the medical cannabis community, announces it has comp...

Partnership Underway to Develop Extensive Protocols and Submissions for US Food & Drug Administration to Uncover Safety and Efficacy for Targeted Medical Cannabis Treatments in the US CB2 chosen to advance application with the US FDA for study on safety and efficacy of cannabis-ba...

TORONTO, Jan. 08, 2020 (GLOBE NEWSWIRE) -- CB2 Insights (CSE:CBII; OTCQB: CBIIF) (“CB2” or the “Company”), a leading data-driven company focused on bringing real-world evidence driven from the point-of-care to the medical cannabis community, today released its CE...

Prospective trial marks first-of-its-kind study on the efficacy and safety of hemp-based CBD treatment focused on patients with anxiety Announcement follows the passage of the 2018 US Farm Bill which legalized the mass production of hemp, a form of cannabis with lower THC levels than mari...

Licensed Producers and Multi-State Operators are recognizing the volumes of data they hold from production, retail, medical and product information but currently exist on disparate platforms across multiple geographies. Company completes full-scale platform development for a cloud-based ...

TORONTO, Dec. 11, 2019 (GLOBE NEWSWIRE) -- CB2 Insights  (CSE:CBII; OTCQB: CBIIF) (“ CB2 ” or the “ Compan y ”), a leading data-driven company focused on bringing real-world evidence-driven from the point-26of-care to the medical cannabis community, announ...

TORONTO, Dec. 03, 2019 (GLOBE NEWSWIRE) -- CB2 Insights (CSE:CBII; OTCQB: CBIIF) (“CB2” or the “Company”), a leading data-driven company focused on bringing real-world evidence-driven from the point-of-care to the medical cannabis community, today announced that ...

Point Roberts, WA and Delta, BC - November 15, 2019 (Investorideas.com Newswire) Investorideas.com , a global news source and leading investor resource announces its weekly roundup of stocks added to its global stock directories in mining, cannabis, food & beverage, greentech, and cyberse...